A detailed history of Focus Financial Network, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Focus Financial Network, Inc. holds 3,920 shares of EXAS stock, worth $237,395. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,920
Holding current value
$237,395
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$42.43 - $70.83 $166,325 - $277,653
3,920 New
3,920 $267 Million
Q1 2024

Apr 24, 2024

BUY
$56.27 - $73.77 $181,752 - $238,277
3,230 New
3,230 $205 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Focus Financial Network, Inc. Portfolio

Follow Focus Financial Network, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focus Financial Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Focus Financial Network, Inc. with notifications on news.